Estracyt
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
SummaryThe pharmacokinetics of estramustine phosphate (EMP) was studied in five prostatic cancer patients given single i.v. and…
Plasma concentrations of estramustine phosphate and its major metabolites were measured in patients with prostatic carcinoma…
Two hundred and twelve patients treated for prostatic cancer grade I or II were investigated for cardiovascular complications…
81 patients with advanced prostate carcinoma, mainly estrogen resistant, were treated with Estracyt. After a pilot study had…
Biopsy material from primary prostatic carcinoma from 25 patients was analyzed with regard to cytosol content of methyltrienolone…
Estramustine phosphate (Estracyt) was used in the treatment of 154 patients with carcinoma of the prostate in stage IV. Sixty…
Estraumustine phosphate (estradiol, 3-N-[bis(2-chloroethyl)-] carbamate-17beta-dihydrogenphosphate (Estracyt) labeled with 3H in…
Sixty-five patients with advanced prostatic carcinoma that had not responded to conventional therapy were treated with Estracyt…